24/7 Patient Assistance: 760-405-8205

Michel Kuzur, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer

Hospitals & Clinics

  • Bio & Insurance Information


    Insurance Accepted

    Aetna Choice POS IIAetna HMO


  • Education & Training

    dept_icon

    of Massachussetts Memorial Healthcare

    Residency

    dept_icon

    Vanderbilt University

    Fellowship

    dept_icon

    American University of Beirut Faculty of Medicine

    Medical School

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Michel Kuzur has contributed to 3 publications.

    Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network

    Greco, F.A., Spigel, D.R., Kuzur, M.E., Shipley, D., Gray, J.R., Thompson, D.S., Burris, H.A., Yardley, D.A., Pati, A., Webb, C.D., Gandhi, J.G., Hainsworth, J.D.; Clin Lung Cancer. 2007 Sep.

    See more >>

    Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.

    Hainsworth, J.D., Spigel, D.R., Raefsky, E.L., Kuzur, M.E., Yost, K., Kommor, M., Litchy, S., Greco, F.A.; Cancer. 2005 Nov 1.

    See more >>

    Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

    Jones, S.F., Burris, H.A., Hainsworth, J.D., Yardley, D.A., Raefsky, E.A., Miranda, F.T., Kuzur, M.E., Willcutt, N.T., White, M.B., Greco, F.A.; Oncology (Williston Park). 2003 May.

    See more >>